CASE Op-Ed – Washington Examiner: Left Taking Their Ideological Agenda to the Bank
Gerard Scimeca – Chairman, CASE January 26, 2020 The enduring benefit of the free-market for every consumer is that...
Gerard Scimeca – Chairman, CASE January 26, 2020 The enduring benefit of the free-market for every consumer is that...
December 23, 2019 In what could have been the policy hallmark of his first term in office, President Trump originally...
Gerard Scimeca – Chairman, CASE July 15, 2019 https://bit.ly/2XO2ymF President Trump schooled Democrats once again last month with the announcement...
Matthew Kandrach – CASE President July 10, 2019 he Trump administration continues to deregulate in sensible ways across the government, unshackling...
Gerard Scimeca – Chairman, CASE June 20, 2019 A CNN poll last month showed President Trump with his strongest numbers...
Gerard Scimeca – Chairman, CASE June 18, 2019 Establishing free and fair trade agreements between the United States and...
Matthew Kandrach – President, CASE June 11, 2019 With America’s reliance on imported minerals rising rapidly, the last thing we...
June 5, 2019 CASE today praised the Trump administration and Department of the Interior Secretary David Bernhardt for the release...
Gerard Scimeca – Chairman, CASE April 25, 2019 – https://bit.ly/2XJhPpq If your neighbor planned to fit her home with solar panels,...
Matthew Kandrach – President, CASE April 15, 2019 – https://bit.ly/2GibbPD Across the country, scores of coal plants are shutting down and...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/
© 2024 · Case for Consumers